Benzinga · Oct 26, 2026
Estrella Immunopharma Appoints Cynthia Pussinen CEO, Chairperson, Effective Oct. 25, Succeeding Cheng Liu
Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation ARTEMIS® T-cell therapies for the treatment of cancer and

